Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

No doubt... This is where FDA oversight is

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Venture_Cap Member Profile
 
Followed By 71
Posts 7,897
Boards Moderated 1
Alias Born 09/28/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2021 5:26:03 PM
Proxy Statement - Contested Solicitations (preliminary) (prec14a) Edgar (US Regulatory) - 7/20/2021 5:06:54 PM
CytoDyn to hold webcast on July 22 to discuss cancer, NASH, and COVID-19 trials Seeking Alpha - 7/20/2021 12:01:04 AM
CytoDyn reports preliminary leronlimab results from mid-stage breast cancer study Seeking Alpha - 7/19/2021 6:19:22 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/12/2021 6:31:24 PM
CytoDyn advances leronlimab into Phase 2 stage in breast cancer trial Seeking Alpha - 7/12/2021 7:10:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/9/2021 5:12:45 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 7/7/2021 4:17:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/6/2021 4:31:55 PM
CEO Presenting on the Emerging Growth / Investors Hub Joint Conference Tomorrow.  Register Now InvestorsHub NewsWire - 7/6/2021 7:00:00 AM
CytoDyn submits dose justification report to FDA for leronlimab BLA in HIV Seeking Alpha - 7/2/2021 1:55:53 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 7/1/2021 5:28:14 PM
CLNV Targets $300 Billion Food Packaging Industry With Environmentally Sustainable Biodegradable Alternative InvestorsHub NewsWire - 6/22/2021 9:55:37 AM
CEO Presenting on the First Emerging Growth / Investors Hub Joint Conference Tomorrow!  Register Now InvestorsHub NewsWire - 6/22/2021 7:00:00 AM
CytoDyn posts preliminary results from COVID-19 long-haulers study Seeking Alpha - 6/21/2021 9:38:56 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/15/2021 5:01:59 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/8/2021 4:32:22 PM
CEO's Presenting at Emerging Growth Conference Virtually Tomorrow InvestorsHub NewsWire - 6/8/2021 7:00:00 AM
CytoDyn's partner to submit request to conduct Phase 3 leronlimab studies in Brazil Seeking Alpha - 5/27/2021 6:33:58 AM
Statement of Beneficial Ownership (sc 13d) Edgar (US Regulatory) - 5/24/2021 5:16:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 5:18:50 PM
CytoDyn promotes Antonio Migliarese to CFO role Seeking Alpha - 5/20/2021 5:14:56 PM
IQST Signals BUY InvestorsHub NewsWire - 5/20/2021 9:43:19 AM
CytoDyn to submit CD12 trial data to regulatory agencies in multiple countries Seeking Alpha - 5/18/2021 7:45:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/17/2021 5:02:38 PM
Venture_Cap   Tuesday, 08/04/20 11:50:15 AM
Re: Amatuer17 post# 101934
Post # of 175765 
No doubt... This is where FDA oversight is needed but who oversees the FDA?



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences